Fibrinolysis and COVID‐19: A tale of two sites?
Charithani B. Keragala, Robert L. Medcalf, Paul S. Myles
Topics & Concepts
MedicineD-dimerFibrinolysisCoronavirus disease 2019 (COVID-19)Internal medicineCoagulopathyCoagulationAntithrombinAnticoagulantIntensive care medicineDiseaseHeparinInfectious disease (medical specialty)COVID-19 Clinical Research StudiesVenous Thromboembolism Diagnosis and ManagementCOVID-19 and healthcare impacts